Total Payments
$1,953
2024 Payments
$274.61
Companies
20
Transactions
98
Medicare Patients
1,063
Medicare Billing
$131,683
Payment Breakdown by Category
Food & Beverage$1,953 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,953 | 98 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Indivior Inc. | $428.53 | 24 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $374.30 | 22 | $0 (2024) |
| Novo Nordisk Inc | $157.75 | 3 | $0 (2022) |
| Lundbeck LLC | $118.67 | 7 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $117.06 | 5 | $0 (2024) |
| ABBVIE INC. | $100.92 | 6 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $81.11 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $80.60 | 4 | $0 (2021) |
| Lilly USA, LLC | $78.85 | 4 | $0 (2023) |
| Merck Sharp & Dohme Corporation | $62.14 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $274.61 | 12 | Otsuka America Pharmaceutical, Inc. ($82.60) |
| 2023 | $262.20 | 14 | Indivior Inc. ($134.69) |
| 2022 | $347.27 | 13 | Novo Nordisk Inc ($133.74) |
| 2021 | $249.76 | 14 | Indivior Inc. ($81.21) |
| 2020 | $277.16 | 17 | Otsuka America Pharmaceutical, Inc. ($63.51) |
| 2019 | $166.86 | 10 | Indivior Inc. ($74.13) |
| 2018 | $190.14 | 11 | Otsuka America Pharmaceutical, Inc. ($46.92) |
| 2017 | $184.99 | 7 | AstraZeneca Pharmaceuticals LP ($84.22) |
All Payment Transactions
98 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $16.55 | General |
| Category: PSYCHIATRY | ||||||
| 11/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $27.74 | General |
| Category: PSYCHIATRY | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $65.03 | General |
| Category: PSYCHIATRY | ||||||
| 08/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.14 | General |
| Category: Central Nervous System | ||||||
| 04/23/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), REXULTI | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: PSYCHIATRY | ||||||
| 04/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: NEUROSCIENCE | ||||||
| 03/21/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: PSYCHIATRY | ||||||
| 03/12/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: PSYCHIATRY | ||||||
| 11/28/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: OUD | ||||||
| 10/25/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: OUD | ||||||
| 09/05/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: PSYCHIATRY | ||||||
| 08/16/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: OUD | ||||||
| 07/25/2023 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: PSYCHIATRY | ||||||
| 06/15/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $25.98 | General |
| Category: OUD | ||||||
| 05/18/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: OUD | ||||||
| 04/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.26 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Diabetes | ||||||
| 03/14/2023 | Indivior Inc. | SUBLOCADE (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: OUD | ||||||
| 03/08/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 221 | 438 | $56,586 | $29,690 |
| 2022 | 5 | 274 | 531 | $66,175 | $34,044 |
| 2021 | 4 | 274 | 543 | $63,961 | $35,341 |
| 2020 | 6 | 294 | 608 | $69,218 | $32,609 |
Total Patients
1,063
Total Services
2,120
Medicare Billing
$131,683
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 201 | $25,125 | $11,683 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 69 | 131 | $19,650 | $9,694 | 49.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $3,969 | $3,778 | 95.2% |
| 90832 | Psychotherapy, 30 minutes | Office | 2023 | 17 | 56 | $4,449 | $2,966 | 66.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 13 | 13 | $3,393 | $1,569 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 272 | $34,000 | $14,558 | 42.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 65 | 109 | $16,350 | $8,910 | 54.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 61 | 61 | $6,365 | $6,133 | 96.4% |
| 90832 | Psychotherapy, 30 minutes | Office | 2022 | 34 | 76 | $6,067 | $3,065 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $3,393 | $1,376 | 40.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 109 | 257 | $32,125 | $14,041 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 61 | 108 | $16,200 | $8,808 | 54.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 61 | 61 | $6,283 | $6,283 | 100.0% |
| 90832 | Psychotherapy, 30 minutes | Office | 2021 | 43 | 117 | $9,353 | $6,209 | 66.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 105 | 287 | $35,900 | $13,080 | 36.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 58 | 110 | $16,350 | $7,348 | 44.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 60 | 60 | $6,259 | $6,179 | 98.7% |
| 90832 | Psychotherapy, 30 minutes | Office | 2020 | 47 | 127 | $10,119 | $5,486 | 54.2% |
| 90756 | Vaccine for influenza for injection into muscle | Office | 2020 | 11 | 11 | $330.00 | $304.70 | 92.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 13 | 13 | $260.00 | $210.60 | 81.0% |
About Dr. Jasmin Breitung, M.D
Dr. Jasmin Breitung, M.D is a Internal Medicine healthcare provider based in Las Vegas, New Mexico. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1891726048.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasmin Breitung, M.D has received a total of $1,953 in payments from pharmaceutical and medical device companies, with $274.61 received in 2024. These payments were reported across 98 transactions from 20 companies. The most common payment nature is "Food and Beverage" ($1,953).
As a Medicare-enrolled provider, Breitung has provided services to 1,063 Medicare beneficiaries, totaling 2,120 services with total Medicare billing of $131,683. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Las Vegas, NM
- Active Since 07/05/2006
- Last Updated 06/10/2008
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1891726048
Products in Payments
- SUBLOCADE (Drug) $428.53
- REXULTI (Drug) $384.04
- VRAYLAR (Drug) $133.05
- Rybelsus (Drug) $125.00
- CAPLYTA (Drug) $124.59
- FARXIGA (Drug) $117.06
- ELIQUIS (Drug) $95.57
- ABILIFY MAINTENA (Drug) $74.27
- INGREZZA (Drug) $51.12
- JARDIANCE (Drug) $49.68
- LifeVest (Device) $47.89
- TRINTELLIX (Drug) $42.14
- TRULICITY (Drug) $36.87
- JANUVIA (Drug) $28.60
- AUSTEDO (Drug) $27.26
- Austedo XR (Drug) $25.14
- MOUNJARO (Drug) $24.76
- RYBELSUS (Drug) $24.01
- Prolia (Biological) $19.82
- ASMANEX (Drug) $19.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Las Vegas
Fadi Braiteh, M.d, M.D
Internal Medicine — Payments: $4.0M
Internal Medicine $4.0M
Samer Nakhle, Md, MD
Internal Medicine — Payments: $911,236
Internal Medicine $911,236
Maxine Ingham, Md, MD
Internal Medicine — Payments: $602,393
Internal Medicine $602,393
Richard Cottiero, Md, MD
Internal Medicine — Payments: $289,614
Internal Medicine $289,614
Dr. Michael Jacobs, M.d., Ph.d, M.D., PH.D
Internal Medicine — Payments: $237,373
Internal Medicine $237,373
Dr. Kevin Dunsmoor, Do, DO
Internal Medicine — Payments: $197,836
Internal Medicine $197,836